BioCentury
ARTICLE | Clinical News

Fibrillex regulatory update

July 12, 2004 7:00 AM UTC

NRM said FDA will include Fibrillex in the agency's continuous marketing application (CMA) Pilot 2 program. The oral small molecule inhibitor of amyloid fiber formation has Fast Track and Orphan Drug ...